Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Richter

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Translational Medicine|June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regimeSolange Moll, Yukari Yasui, Ahmed Abed, et al.
Chembiochem : a European Journal of Chemical Biology|November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live CellsThais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
European Journal of Medicinal Chemistry|September 22, 2022
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brainYingfang He, Uwe Grether, Marco F Taddio, et al.
ACS Chemical Biology|November 20, 2018
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport SyndromeHans Richter, Alexander L Satz, Marc Bedoucha, et al.
Journal of Medicinal Chemistry|October 3, 2024
Structure-Guided Discovery of <i>cis</i>-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase InhibitorsBernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Translational Medicine|June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regimeSolange Moll, Yukari Yasui, Ahmed Abed, et al.
Chembiochem : a European Journal of Chemical Biology|November 28, 2024
Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live CellsThais Gazzi, Benjamin Brennecke, Valentas Olikauskas, et al.
European Journal of Medicinal Chemistry|September 22, 2022
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brainYingfang He, Uwe Grether, Marco F Taddio, et al.
ACS Chemical Biology|November 20, 2018
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport SyndromeHans Richter, Alexander L Satz, Marc Bedoucha, et al.
Journal of Medicinal Chemistry|October 3, 2024
Structure-Guided Discovery of <i>cis</i>-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase InhibitorsBernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Pageof 3